Debate 4: That targeted therapy and endocrine treatment should be combined upfront before endocrine resistance develops
Session 4 : Her2 -ve/ Er+ve Metastatic Breast Cancer
Chairpersons :
Dr. Shyamal Sarkar, Dr. Litan Naha Biswas
Moderator :
Dr. Sharadwat Mukhopadhyay